Blog

Leveraging Decentralized Real-World Evidence (RWE) Data Collection Strategies During the COVID-19 Pandemic and Beyond

New and Emerging Regulatory Guidance for Cell and Gene Therapy Product Development

The Critical Need for Pregnancy Registry Studies and Robust Safety Monitoring in COVID-19 Vaccines

Predicting Extractables & Leachables Amounts using Mathematical Modeling

Overcoming Barriers to Large Global Studies: Cardiovascular Outcomes and Vaccine Trial Leaders on Research Methods That Made a Difference

Moderna Announces FDA Authorization of Moderna COVID-19 Vaccine in U.S.

Time to Act is Now: Paediatrics Medicines Development in the UK

Early Engagement Strategies to Set Cell & Gene Therapies Up for Success

Moderna’s COVID-19 Vaccine Candidate Meets its Primary Efficacy Endpoint in the First Interim Analysis of the Phase 3 COVE Study